Category: CovidienSyndicate content

FDA OKs Covidien's Nellcor portable oxygen monitor

October 10, 2014 by Alexander Soule

The FDA green-lights Covidien's Nellcor portable SpO2 monitor for home use in adults and infants.

FDA okays Covidien's Nellcor portable oxygen monitor

The FDA gave the green light to Covidien's (NYSE:COV) Nellcor portable SpO2 monitor, which is used to monitor oxygen and pulse levels in the home.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic announces leadership roster for post-Covidien merger

October 10, 2014 by Brad Perriello

Medtronic reveals the leadership team slated to lead the company after its mega-merger with Covidien.

Medtronic announces roster for post-Covidien merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower

October 8, 2014 by Brad Perriello

Covidien's Ev3 subsidiary logs a pair of legal wins, with the Delaware Supreme Court reversing a $250 million loss to Appriva and a Massachusetts federal judge tossing a whistleblower's lawsuit.

Covidien's ev3 logs a pair of legal wins over Appriva, whistleblower

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Peripherals transition team named in Medtronic, Covidien merger | The week in medtech M&A

October 8, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Medtronic, Covidien name peripherals biz transition team; Medtronic is still in on Covidien buyout; The Street cheers changes to the Medtronic, Covidien deal; Zimmer adds Harvard spinout Etex Corp.; EU to extend Zimmer, Biomet probe

Medtronic, Covidien name peripherals biz transition team

October 1, 2014 by Alex Soule

Medical device tax 'exactly as we have feared,' AdvaMed CEO Ubl says

October 8, 2014 by Brian Johnson

The medical device industry's fears about the medical device tax have borne out, making its repeal a top agenda item for AdvaMed CEO Stephen Ubl.

Medical device tax 'exactly as we have feared,' AdvaMed's Ubl says

Time has not healed all wounds when it comes to the medical device tax. Nearly 2 years after implementation, the levy has played out according to script, AdvaMed president & CEO Stephen Ubl said this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

Medtronic reveals that the tax tab for its top executives from its Covidien buyout will near $58 million, apart from the capital gains taxes all shareholders will pay on the $43 billion deal.

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AdvaMed in the age of consolidation

October 6, 2014 by Brian Johnson

What does news of yet another mega-merger mean for medtech's industry council?

regular_avm14_press_conference_photo.jpg

The winds of change in medtech are blowing in the Windy City.

As medtech's best & brightest descended on Chicago for another annual confab at AdvaMed 2014, it was impossible to ignore that the industry has now entered the great age of consolidation with yet another multibillion-dollar healthcare deal.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp